Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Progenics Pharmaceuticals
PGNX

Buy Progenics Pharmaceuticals (PGNX) Stock

PGNX
See PGNX stock price and Buy/Sell Progenics Pharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
PGNX

Progenics Pharmaceuticals (PGNX)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About Progenics Pharmaceuticals (PGNX)

Progenics Pharmaceuticals, Inc., of Tarrytown, N.Y., is a biopharmaceutical company focused on innovative therapeutics for patients suffering from cancer and related conditions. Progenics' pipeline candidates include PSMA ADC, a human monoclonal antibody-drug conjugate in phase 2 testing for treatment of prostate cancer, and preclinical stage novel multiplex phosphoinositide 3-kinase (PI3K) inhib...Read more
Market Cap
$355.05M
1 Year High
$6.37
Volume
1 Year Low
$1.89
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch PGNX stock

Progenics Pharmaceuticals Stock News

Themes

Explore other stocks like PGNX in these curated Themes.
Fighting Disease

Progenics Pharmaceuticals stock rating

What analysts recommend for PGNX stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1

Progenics Pharmaceuticals price target

What analysts think PGNX will be worth
Low $0
High $6.50
Current $0
Target $6.50

Events

List of events that could affect PGNX stock.
07May

Earnings data Q1 2020

07Aug

Earnings data Q2 2020

Progenics Pharmaceuticals earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.08
-0.16
-0.24
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020

Expected EPS
Q4 2020
-$0.22
Actual EPS
Q4 2020

Buy Progenics Pharmaceuticals (PGNX) Stock

PGNX
See PGNX stock price and Buy/Sell Progenics Pharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch PGNX stock
  • lucky01lost avatar
  • tmcghie avatar
  • ShaunM avatar
  • bmwilli2 avatar
  • bigwilly2212 avatar

Themes

Explore other stocks like PGNX in these curated Themes.
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.